Using cell mass to determine response to treatment: A possible cure?
How to manage infections after hematopoietic stem cell transplantation and the issue of resistance
Biomarkers for acute myeloid leukemia (AML) – lessons from IL-2 immunotherapy with HDC
Matched unrelated donor (MUD) transplantations for ALL and AML
Trials of BiTEs for the treatment of acute leukemias